Advertisement

Alzheimer’s Disease and Parkinson’s Disease with Dementia: Comparison of Cortical Blood Flow Demonstrated by Three-Dimensional Surface Display

  • K. Kawabata
  • H. Tachibana
  • Y. Tomino
  • M. Takeda
  • B. Okuda
  • M. Sugita
Part of the Advances in Behavioral Biology book series (ABBI, volume 44)

Abstract

Cognitive impairment is a well recognized feature of patients with Parkinson’s disease as well as Alzheimer’s distice. Although the pattern of cognitive dysfunction is not identical, the two diseases share many neuropathological1 and neurochemical2 features. This study was conducted to compare the brain perfusion image using three-dimensional surface (3D) display in Parkinson’s disease with that in Alzheimer’s disease. 3D surface display may be superior to tomographic images for diagnosing the extent of cerebral cortical hypoperfusion,3 since the physician must integrate information from a large number of single photon emission computed tomography (SPECT) images to evaluate low perfusion lesions stereoscopically.

Keywords

Single Photon Emission Compute Tomography Perfusion Defect Surface Display Cortical Blood Flow Single Photon Emission Compute Tomography Scanning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.M. Candy, R.H. Perry, E.K. Perry, D. Irving, G. Blessed, A.F. Fairbrain, and B.E. Tomlinson Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s disease, J. Neurol. Sci. 59: 277–289 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    M. Ruberg, A. Ploska, F. Javoy-Agid, and Y. Agid, Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia, Brain Res. 232: 129–139 (1982).PubMedCrossRefGoogle Scholar
  3. 3.
    N. Honda, K. Machida, T. Mamiya, T. Takabashi, T. Takishima, T. Kamano, S. Tamaki, M. Muramatsu, and R. Ban, Value of three-dimensional surface display of brain perfusion imaging. Comparison with tomographic imaging, Clin. Nucl. Med. 17: 106–109 (1992).PubMedCrossRefGoogle Scholar
  4. 4.
    J. Ishimura, M. Fukuchi, Clinical application of three dimensional surface display in brain imaging with Tc-99m HMPAO, Clin. Nucl. Med. 16: 343–351 (1991).PubMedCrossRefGoogle Scholar
  5. 5.
    K.A. Johnson, S.T. Mueller, T.M. Walshe, R.I. English, and B.L. Holman, Cerebral perfusion imaging in Alzheimer’s disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch. Neurol. 44: 165–168 (1987).PubMedCrossRefGoogle Scholar
  6. 6.
    I. Goto, T. Taniwaki, S. Hosokawa, M. Otsuka, Y. Ichiva, and A. Ichimiva, Positron emission tomo graphic (PET) studies in dementia, J. Neurol. Sci. 114: 1–6 (1993).PubMedCrossRefGoogle Scholar
  7. 7.
    G.T. Lenzi, T. Jones, J.L. Reid, and S. Moss, Regional impairment of cerebral oxidative metabolism in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry 42: 59–62 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    P.T. Fox, M.E. Raichle, M.A. Mintun, and C. Dence, Nonoxidative glucose consumption during focal physiologic neural activity, Science 241: 462–464 (1988).PubMedCrossRefGoogle Scholar
  9. 9.
    W.R.G. Gibb, Dementia and Parkinson’s disease, Br. J. Psychiatry 154: 596–614 (1989).PubMedCrossRefGoogle Scholar
  10. 10.
    R.S. Hellman, R.S. Tikofsky, B.D. Collier, R.G. Hoffman, D.W. Palmer, S.L. Glatt, P.G. Antuono, A.T. Isitman, and R.A. Papke, Alzheimer disease: Quantitative analysis of I-123-Iodoamphetamine SPECT brain imaging, Radiology 172: 183–188 (1989).PubMedGoogle Scholar
  11. 11.
    B.L. Holman, K.A. Johnson, B. Gerada, P.A. Carvalho, and A. Satlin, The scintigraphic appearance of Alzheimer’s disease• a prospective study using technetium-99m-HMPAO SPECT, J. Nucl. Med. 33: 181–185 (1992).PubMedGoogle Scholar
  12. 12.
    F. Boller, T. Mizutani, U. Roessmann, and P. Gambetti, Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations, Ann. Neurol. 7: 329–335 (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    H.O. Habert, U. Spampinato, J.L. Mas, M.L. Piketty, M.C. Bourdel, J. de Recondo, P. Rondot, and S. Askienazy, A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia, Eur. J. Nucl. Med. 18: 3–11 (1991).PubMedCrossRefGoogle Scholar
  14. 14.
    K. Kawabata, H. Tachibana, M. Sugita, and M. Fukuchi, A comparative I-123 SPECT study in Binswanger’s disease and Alzheimer’s disease, Clin. Nucl. Med. 18: 329–336 (1993).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • K. Kawabata
    • 1
  • H. Tachibana
    • 1
  • Y. Tomino
    • 1
  • M. Takeda
    • 1
  • B. Okuda
    • 1
  • M. Sugita
    • 1
  1. 1.Fifth Department of Internal MedicineHyogo College of MedicineNishinomiya, 663Japan

Personalised recommendations